Literature DB >> 23896480

Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.

Naoyuki Miyashita1, Hiroto Akaike, Hideto Teranishi, Kazunobu Ouchi, Niro Okimoto.   

Abstract

We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P = 0.0361 and P = 0.0237, respectively).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23896480      PMCID： PMC3811443          DOI： 10.1128/AAC.00737-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.

Authors:  N Okazaki; M Narita; S Yamada; K Izumikawa; M Umetsu; T Kenri; Y Sasaki; Y Arakawa; T Sasaki
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Guidelines for the management of community acquired pneumonia in adults, revised edition.

Authors: 
Journal:  Respirology       Date:  2006-09       Impact factor: 6.424

4.  Clinical differentiation of atypical pneumonia using Japanese guidelines.

Authors:  Tadashi Ishida; Naoyuki Miyashita; Chikara Nakahama
Journal:  Respirology       Date:  2007-01       Impact factor: 6.424

5.  Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Authors:  Satowa Suzuki; Tsutomu Yamazaki; Mitsuo Narita; Norio Okazaki; Isao Suzuki; Tomoaki Andoh; Mayumi Matsuoka; Tsuyoshi Kenri; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study.

Authors:  Naoyuki Miyashita; Hiroshi Fukano; Keiji Mouri; Minoru Fukuda; Koichiro Yoshida; Yoshihiro Kobashi; Yoshihito Niki; Mikio Oka
Journal:  J Med Microbiol       Date:  2005-04       Impact factor: 2.472

7.  Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Authors:  Mayumi Matsuoka; Mitsuo Narita; Norio Okazaki; Hitomi Ohya; Tsutomu Yamazaki; Kazunobu Ouchi; Isao Suzuki; Tomoaki Andoh; Tsuyoshi Kenri; Yuko Sasaki; Atsuko Horino; Miharu Shintani; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.

Authors:  Naoyuki Miyashita; Tadaaki Sugiu; Yasuhiro Kawai; Keiko Oda; Tetsuya Yamaguchi; Kazunobu Ouchi; Yoshihiro Kobashi; Mikio Oka
Journal:  BMC Med Imaging       Date:  2009-04-29       Impact factor: 1.930

10.  Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography.

Authors:  Isao Ito; Tadashi Ishida; Kaori Togashi; Akio Niimi; Hiroshi Koyama; Takayoshi Ishimori; Hisataka Kobayashi; Michiaki Mishima
Journal:  Eur J Radiol       Date:  2008-10-02       Impact factor: 3.528
View more
  19 in total

1.  Rapid Detection of the Macrolide Sensitivity of Pneumonia-Causing Mycoplasma pneumoniae Using Quenching Probe Polymerase Chain Reaction (GENECUBE®).

Authors:  Yutaka Ito; Satoru Iwashima; Satoshi Hayano; Tomohiro Nishio; Ryosuke Shiozawa; Soichiro Yata; Toshiko Kubota; Akira Kubota; Keiichi Uemura
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

2.  Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.

Authors:  Naoto Ishimaru; Satoshi Suzuki; Toshio Shimokawa; Yusaku Akashi; Yuto Takeuchi; Atsuo Ueda; Saori Kinami; Hisashi Ohnishi; Hiromichi Suzuki; Yasuharu Tokuda; Tetsuhiro Maeno
Journal:  Intern Emerg Med       Date:  2021-05-13       Impact factor: 3.397

Review 3.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 4.  Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?

Authors:  Ruby Cross; Clare Ling; Nicholas P J Day; Rose McGready; Daniel H Paris
Journal:  Expert Opin Drug Saf       Date:  2016-01-25       Impact factor: 4.250

Review 5.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

Review 6.  Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.

Authors:  Nicholas W Carris; Joe Pardo; Jose Montero; Kristy M Shaeer
Journal:  Open Forum Infect Dis       Date:  2015-11-25       Impact factor: 3.835

7.  Fluoroquinolone and no risk of Achilles-tendinopathy in childhood pneumonia under eight years of age-a nationwide retrospective cohort.

Authors:  Yunsun Kim; Gun Woo Park; Sangyoung Kim; Hui Jeong Moon; Sungho Won; Wankyo Chung; Hyeon-Jong Yang
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

Review 8.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

Review 9.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640

10.  A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin.

Authors:  Yoko Matsuda; Yoshitsugu Chigusa; Eiji Kondoh; Isao Ito; Yusuke Ueda; Masaki Mandai
Journal:  Case Rep Obstet Gynecol       Date:  2017-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.